Use of Medicinal Cannabis for Epilepsy in the Australian Community 2023–2024: A Cross-Sectional Survey

Abstract Background and Purpose: Epilepsy is a common indication for medicinal cannabis (MC) prescription in Australia. Despite legal MC products being available for 8 years, some individuals continue to rely on illicit cannabis. Here, we conducted a survey of Australian persons/people with epilepsy (PWE) and caregivers of a PWE to assess whether the current legal framework supports PWE and/or their caregivers to access prescribed MC. Methods: The cross-sectional survey consisted of five sections examining sociodemographics, medical history, history of MC